4-Androstenediol
4-Androstenediol is a testosterone prohormone that converts downstream into testosterone-like activity. It was one of the original “legal steroid” products before regulatory changes moved it into anabolic steroid territory.
Its main use is mild androgenic support, often in prohormone-style setups where users want more libido, mood, recovery, and fullness without injecting testosterone. It is less predictable and less efficient than direct testosterone.
4-AD is usually chosen by users who want a low-intimidation androgen base for a prohormone or oral-only setup. It is often used to offset lethargy and low-libido symptoms from suppressive dry compounds rather than as the main anabolic driver.
4-AD also attracts people who are not ready to inject. That does not make it a better testosterone base, just a more approachable one. Direct testosterone is more predictable, more efficient, and easier to verify with bloodwork.
Administration: Oral compound. Most users take it with a fixed daily schedule rather than chasing short-term effect swings.
Support planning: Build the rest of the cycle around the actual downside profile of this compound, not just the look or strength result it promises.
Stop or reduce if: blood pressure climbs, sleep degrades, libido crashes, or labs move sharply in the wrong direction.
The feel can show up quickly because the compound is oral and short-acting, but body-composition changes are modest. Users should expect support, not transformation. If the goal is a first injectable-style cycle, 4-AD is usually a detour compared with learning testosterone properly.
Dose-response is noisy because products vary and conversion is individual. The user should judge it by bloodwork, libido, mood, water retention, and whether it actually solves the low-androgen feel it was added for.
4-Androstenediol, usually shortened to 4-AD or 4-Andro, is a testosterone prohormone. It converts downstream into testosterone-like activity, giving users a milder, oral entry into androgen exposure without injecting testosterone directly.
That convenience is also the limitation. 4-AD is less efficient than testosterone because the body has to convert it first, and conversion varies heavily by person and product. When it works, the user gets a mild testosterone-like feel: better mood, libido, fullness, recovery, and some strength. When it underperforms, it feels like an expensive supplement with real suppression attached.
Because the endpoint is testosterone-like activity, estrogen can still matter. Testosterone produced from conversion can aromatize into estradiol, so water retention, nipple sensitivity, and mood changes are possible. Calling it a prohormone does not remove the hormone-management problem.
The main mistake is treating 4-AD like a loophole. It is still hormonal, still suppressive, and still capable of estrogen-related side effects.
Another mistake is expecting it to carry a cycle the way injectable testosterone does. It may provide enough androgenic support for a mild prohormone stack, but it is less predictable than a real test base.
Compared with Testosterone, 4-AD is less predictable and less efficient. Testosterone gives a clearer dose-to-lab relationship and a cleaner management model.
Compared with SARMs, 4-AD is more hormone-base-like. SARMs directly bind androgen receptors without aromatizing, while 4-AD can create testosterone and estradiol downstream.
Compared with Dianabol as an oral base idea, 4-AD is usually milder and less dramatic. Dbol gives stronger anabolic and estrogenic feedback; 4-AD is more about replacing some androgenic feel.
Natural suppression with reduced fertility and testicular output
High estradiol, water retention, and gynecomastia risk if estrogen is unmanaged
CBC / hematocrit
blood pressure
lipid panel
estradiol
Uncontrolled hypertension or untreated cardiovascular disease
Pre-existing severe infertility concerns unless that risk is accepted and managed
Current uncontrolled estrogen-sensitive issues such as active gynecomastia